RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
+35.63%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$969M
AUM Growth
+$969M
Cap. Flow
+$44.9M
Cap. Flow %
4.63%
Top 10 Hldgs %
77.9%
Holding
37
New
5
Increased
8
Reduced
7
Closed
7

Top Buys

1
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$16.9M
2
AVXS
AveXis, Inc. Common Stock
AVXS
$16.2M
3
PTGX icon
Protagonist Therapeutics
PTGX
$15.9M
4
BOLD
Audentes Therapeutics, Inc
BOLD
$12.6M
5
ARDX icon
Ardelyx
ARDX
$12.3M

Top Sells

1
ACRS icon
Aclaris Therapeutics
ACRS
$27.7M
2
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$17M
3
NTRA icon
Natera
NTRA
$9.45M
4
AGRX
Agile Therapeutics, Inc
AGRX
$6.49M
5
CDTX icon
Cidara Therapeutics
CDTX
$4.24M

Sector Composition

1 Healthcare 96.53%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EIGR
26
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$4.74M 0.49%
354,200
+62,500
+21% +$837K
SGMO icon
27
Sangamo Therapeutics
SGMO
$157M
$4.16M 0.43%
899,438
-266,500
-23% -$1.23M
SYRE icon
28
Spyre Therapeutics
SYRE
$996M
$2.16M 0.22%
336,134
-185,416
-36% -$1.19M
ORKA
29
Oruka Therapeutics, Inc. Common Stock
ORKA
$554M
$1.48M 0.15%
521,606
-41,087
-7% -$116K
AKTX
30
Akari Therapeutics
AKTX
$24.8M
$970K 0.1%
114,039
-120,201
-51% -$1.02M
CDTX icon
31
Cidara Therapeutics
CDTX
$1.66B
– –
-410,809
Closed -$4.24M
MRUS icon
32
Merus
MRUS
$4.98B
– –
-237,599
Closed -$1.9M
NTRA icon
33
Natera
NTRA
$23.1B
– –
-783,520
Closed -$9.45M
ZYNE
34
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
– –
-253,468
Closed -$1.74M
AGRX
35
DELISTED
Agile Therapeutics, Inc
AGRX
– –
-853,151
Closed -$6.49M
SRRA
36
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-29,719
Closed -$59K
VTAE
37
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
– –
-1,575,000
Closed -$17M
1
2